Get the newest information from the Immunization Program right in your inbox!
Sign up
Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Complete the online reporting agreement form
Or fill out the
then email it to
vaxreporting@phila.gov
or fax to the contact above.
Complete in addition to the reporting agreement form to onboard more than 2 clinics.
Need help? Review the FAQ
On September 18-19, 2025, CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend: MMRV (combined MMR + varicella) vaccine should not be given to children under 4 years old. It is recommended to administer MMR and varicella vaccines separately. Clinical Background: MMRV Vaccine The MMRV vaccine is a...
VFC providers can now order Moderna, Pfizer, & Sanofi 2025-2026 COVID-19 products for their eligible patients.Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products.These are the vaccines available this year: *Pfizer 6 mos - 4 years is no longer available.**This is a...
On February 14, 2025, the Food and Drug Administration (FDA) approved GSK’s MenABCWY vaccine, Penmenvy, for use in individuals aged 10 through 25 years. Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) is now available through the Vaccines for Children (VFC) program. The vaccine is...
Vaccines for Children (VFC) providers are now welcome to order nirsevimab (Beyfortus) as needed. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025 to March 31, 2026. Once we receive your nirsevimab orders,...
The following products are now available to order: Flulaval (VFC & VFAAR) Fluzone (VFC only) Flucelvax (VFC only) FluMist (VFC only) 2025-2026 Available Influenza Products Vaccines for Children (VFC) Product Manufacture/NDC Eligibility Dose / Presentation / Type CPT Code CVX Code Available FluLaval GSK, 19515-0904-52 6 mos – 18 years 0.5 mL / Single-dose syringe / inactivated, trivalent 90656 140 Yes Fluzone Sanofi, 49281-0425-50 6 mos – 18...
Effective immediately, all 2024-2025 COVID-19 products are no longer approved for use. Remove all 2024-2025 COVID-19 vaccines from storage units immediately, even if they are not expired. Discard any open vials of vaccine and adjust inventory using the Wasting Vaccine Guide. Return any unopened vials or syringes using the Vaccine Return Guide. Mark...
The Philadelphia Immunization Program has free print materials available for your office to order. We recently sent a sample of these materials to your offices, so keep an eye out! Review the materials below and click the button at the bottom of this message to place...
As we prepare for the upcoming 2025-2026 season, our program would like to understand your practice's plans for offering COVID-19 vaccine to pediatric patients in light of recent CDC policy changes. Effective July 1, 2025, Vaccines for Children (VFC) providers are no longer required to order...
Beginning in September, the Philadelphia Immunization Program will be implementing a new ordering process for the Vaccines for Adults at Risk (VFAAR) program. All VFAAR orders should be submitted by the end of the day on the first Wednesday of each month. Orders will be reviewed...
FluLaval pre-filled syringes and Flucelvax pre-filled syringes are now available to order for your VFC-eligible patients. FluLaval pre-filled syringes are now available to order for your VFAAR-eligible patients. Visit our flu webpage to learn more about which vaccines are available and how to place your first order...
The Immunization Champion Award, hosted by the Association of Immunization Managers (AIM) and funded by the Centers for Disease Control and Prevention (CDC), recognizes individuals doing an exemplary job or going above and beyond to promote or foster immunizations in their communities for children and adults. The award...
2025-2026 VFC & VFAAR influenza products will be available to order soon. Make sure your office is ready! Starting Tuesday, August 12, 2025: FluLaval and Flucelvax will be available to order for your VFC-eligible patients. FluLaval will be available to order for your VFAAR-eligible patients. Complete a return in PhilaVax for any...
Join us for an informative virtual session on respiratory viruses. This session is for both primary care physicians (PCPs) and other vaccine providers to learn more about: respiratory syncytial virus (RSV) influenza COVID-19 vaccine ordering, storage, and administration information Infectious disease expert Dr. Mayssa Abuali will give an overview of...
Nirsevimab (Beyfortus) ordering will begin in August for the 2025-2026 season. Nirsevimab (Beyfortus), a monoclonal antibody immunization used to prevent RSV infection in infants and young children, can be administered from October 1, 2025, to March 31, 2026. The CDC plans to continue releasing nirsevimab (Beyfortus) through...
All VFC & VFAAR influenza vaccine supplied by the Philadelphia Immunization Program during the 2024-2025 flu season has expired. Please account for unused VFC & VFAAR flu vaccine at your site using PhilaVax: Process a return for the unopened vials online in the Vaccines Returns module. A job aid with step by...
In the face of rapidly shifting vaccine policies and public uncertainty, it’s more important than ever for healthcare providers to be equipped with tools that foster trust and clarity around vaccination. We’ve developed strategies to support your conversations with patients—strategies that address misconceptions, center patient concerns,...
On May 29, 2025, the CDC updated the routine Child and Adolescent Immunization Schedule. All moderately and severely immunocompromised children should receive the COVID-19 vaccine. All other children may receive the COVID-19 vaccine based on shared decision-making between the patient/parent and the pediatrician, combining the...
Join us for the Philadelphia Immunization Coalition (PIC) adult-focused conference on June 3, 2025, from 8:00 AM – 3:30 PM at the College of Physicians in Philadelphia. Keynote speakers include: Richard Hughes IV, JD, MPH on healthcare and the political climate Paul Offit, MD on vaccine education Topics include: Hepatitis...